CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study Optical coherence tomography and intravascular ultrasound assessment of the anatomic size and wall thickness of a muscle bridge segment Dilated cardiomyopathy: so many cardiomyopathies! Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Circadian-Regulated Cell Death in Cardiovascular Diseases

Original ResearchNov 08, 2021.

JOURNAL:J Am Coll Cardiol Img. Article Link

Plaque Rupture, compared to Plaque Erosion, is associated with Higher Level of Pan-coronary Inflammation

A Nakajima , T Sugiyama , M Araki et al. Keywords: plaque rupture; plaque erosion; inflammation; ASCVD;

ABSTRACT

BACKGROUND - Vascular inflammation plays a key role in plaque rupture, while the role of inflammation in plaque erosion remains less well defined. Peri-coronary adipose tissue (PCAT) attenuation determined by computed tomography has emerged as a marker specific for coronary artery inflammation.

 

OBJECTIVES - To compare the level of coronary inflammation between plaque rupture and plaque erosion using PCAT attenuation.

 

METHODS - Patients with non-ST-segment elevation acute coronary syndromes who underwent pre-intervention coronary computed tomography angiography and optical coherence tomography culprit lesion imaging were enrolled. PCAT attenuation was measured around the culprit lesion and in the proximal 40mm of all coronary arteries.

 

RESULTS - Out of 198 patients, plaque rupture was the underlying mechanism in 107 patients (54.0%) and plaque erosion in 91 (46.0%) patients. Plaque rupture had higher PCAT attenuation than plaque erosion both at the culprit plaque level (-65.8 ± 7.5 vs. -69.5 ± 11.4 Hounsfield unit [HU], p = 0.010) and at the culprit vessel level (-67.1 ± 7.1 vs. -69.6 ± 8.2 HU, p = 0.024). The mean PCAT attenuation of all 3 coronary arteries was also significantly higher in patients with plaque rupture than in plaque erosion indicating a higher level of inflammation (-67.9 ± 5.7 vs. -69.9 ± 6.8 HU, p = 0.030). In multivariable analysis, plaque rupture was significantly associated with high PCAT attenuation.

 

CONCLUSIONS - PCAT attenuation in culprit plaque, culprit vessel, and all 3 coronary arteries was higher in plaque rupture than in plaque erosion. The results suggest pan-coronary inflammation plays a more significant role in plaque rupture than in plaque erosion.